Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.

ABSTRACT:

SUBMITTER: Pontali E 

PROVIDER: S-EPMC7211718 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature